TG Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD 3.73B 5.22B 2025-03
Alaunos Therapeutics USD -755000 395K 2024-12
Amgen USD 1.29B 1.02B 2025-03
Ardelyx USD 8.12M 5.89M 2024-12
Arrowhead Research USD 381.2M 542.61M 2025-03
Bayer EUR 2.32B 1.21B 2025-03
Biogen USD 311.2M 130.2M 2025-03
Corcept Therapeutics USD 3.42M 21.85M 2025-03
Dynavax Technologies USD -23630000 22M 2025-03
Gilead Sciences USD 2.24B 215M 2025-03
J&J USD 13.63B 9.74B 2025-03
Novartis USD 2.28B 1.34B 2024-12
PTC Therapeutics USD 970.22M 1.03B 2025-03
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



TG Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.